| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/02/2005 | EP1501795A1 Cinnamic acid amides |
| 02/02/2005 | EP1165534B1 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575169A Mch antagonists for the treatment of obesity |
| 02/02/2005 | CN1572882A Benzamidine derivatives |
| 02/02/2005 | CN1572803A Process for forming polyalkenyl acylating agents |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187327C Method for production of N-alkenyl amides |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/01/2005 | US6849743 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849713 Topisomerase inhibitor |
| 02/01/2005 | US6849657 Osteoporosis; increase bone density |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 01/27/2005 | WO2005007662A2 Biphosphine ruthenium complexes with chiral diamine ligande as catalysts |
| 01/27/2005 | WO2005007626A1 Kappa agonists, especially for the treatment and/or prophylaxis of irritable bowel syndrome |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020838 Acetylenic compound useful in treating inflammatory disorders |
| 01/27/2005 | US20050020677 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
| 01/27/2005 | US20050020576 Opioid antagonist; analgesics; antiinflammatory agents; side effect reduction |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020518 under physiological conditions, containing a labile disulfide bond and a transduction signal such as transcriptional factor from Drosophila, ANTP; for the delivery of a compound to a cell; disulfide bond cleaved more rapidly than oxidized glutathione |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | CA2531817A1 Kappa agonists, especially for the treatment and/or prophylaxis of irritable bowel syndrome |
| 01/27/2005 | CA2531603A1 Method for production of .alpha., .beta.-unsaturated amide compounds |
| 01/26/2005 | EP1500655A1 New methionine aminopeptidase inhibitor |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499609A2 Pesticidal heterocycles |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499583A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids |
| 01/26/2005 | EP1499297A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 01/26/2005 | EP1353639A4 Primary intermediates for oxidative coloration of hair |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571786A Alkyl ether derivatives or salts thereof |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1569832A Production method of N-octa alkyl-2-pyrrolidone |
| 01/26/2005 | CN1569831A Phenol-containing wastewater extraction agent N-octanoyl pentazane and its synthesis method |
| 01/26/2005 | CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/25/2005 | US6846931 Organic acid salt of amlodipine |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/20/2005 | WO2005005417A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 01/20/2005 | WO2005005416A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 01/20/2005 | WO2005005384A1 Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form |
| 01/20/2005 | WO2005005383A1 Amino alcohol compound |
| 01/20/2005 | WO2005005374A1 Aspartyl protease inhibitors |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2005004803A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2005004802A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2005004796A2 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004098525A9 Uses of ion channel modulating compounds |
| 01/20/2005 | WO2004092126A3 Process and intermediates for the preparation of pyrrolidine carboxylic acids |
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | US20050014954 Pyrrole synthesis |
| 01/20/2005 | US20050014840 Thiol sulfonamide metalloprotease inhibitors |
| 01/20/2005 | US20050014814 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 01/20/2005 | US20050014803 Enzyme inhibitors |
| 01/20/2005 | US20050014789 Psychological disorderas; antidepressants; obsessive complusive disorders; drug abuse; |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014765 Aryl-heteroaromatic products, compositions comprising them and use |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014748 N-type calcium channel blockers |
| 01/20/2005 | US20050014724 Immunosuppressant compounds and compositions |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | US20050014650 Delta 1-pyrrolines used as pesticides |
| 01/20/2005 | US20050014634 Polydentate substituted pyrrole or phosphlane based chelants and metal complexes; polymerization of crystalline high-isotactic polypropylene having high strength and high-temperature heat resistance |
| 01/20/2005 | DE10329457A1 New 1,2-bis-phenylaminocarbonyl-pyrrolidine derivatives, useful for treating or preventing e.g. thrombosis, myocardial infarct and arteriosclerosis, are inhibitors of coagulation factor Xa |
| 01/20/2005 | CA2532068A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 01/20/2005 | CA2532056A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | CA2530006A1 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529994A1 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/19/2005 | EP1498428A1 Antibodies for detecting ecstasy-class analytes |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497284A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497265A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 01/19/2005 | EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1496891A2 Methods for modulating phototoxicity |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1385510A4 Prodigiosin composition for the treatment of rheumatic arthritis |
| 01/19/2005 | EP1347958B1 Process for preparing distamycin derivatives |
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |